{
  "url": "https://openlegislation.uk/royal-pharmaceutical-society-of-great-britain-registration-rules-order-of-council-2007/schedule/paragraph-33",
  "json_url": "https://openlegislation.uk/royal-pharmaceutical-society-of-great-britain-registration-rules-order-of-council-2007/schedule/paragraph-33.json",
  "legislation": "uksi/2007/441",
  "legislation_title": "The Royal Pharmaceutical Society of Great Britain (Registration Rules) Order of Council 2007",
  "legislation_url": "https://openlegislation.uk/royal-pharmaceutical-society-of-great-britain-registration-rules-order-of-council-2007",
  "path": "schedule/paragraph/33",
  "kind": "paragraph",
  "number": "33",
  "heading": "Decision of the Committee",
  "text": "(1) The written notice under article 43(5), shall be given, in addition to the appellant, to—\n(a) the case officer; and\n(b) any other person whom the secretary considers, in the public interest, ought to be informed of the Committee's decision.\n(2) The written notice given to the appellant shall be accompanied by a record of—\n(a) any advice relating to the case tendered by a clinical or specialist adviser;\n(b) any rulings on questions of law or admissibility of evidence made by the chair.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2007/441/schedule/paragraph/33",
    "retrieved_at": "2026-10-29T04:04:50.178587+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}